Knocking out or inhibiting HIF-1α significantly attenuated fibroblast activation by downregulating NF-ĸB signaling with significant reduction of CCL5, a potent pro-inflammatory chemokine and restricted tumor growth [25]. Here, HIF1A is linked to neoplasm.